Table 1 Geographic, Sponsorship, Institutional, and Subtype Distribution of U.S. Uveitis Trials (2000–2023).

From: Unequal Access and Evolving Priorities in U.S. Uveitis Clinical Trials: A 23-year Analysis of Regional, Institutional, and Anatomic trends

Category

Subcategory

Trials (n)

Percent (%)

Region

South

38

38.8

 

West

30

30.6

 

Northeast

16

16.3

 

Midwest

14

14.3

Sponsor Type

Private

54

55.1

 

Public

27

27.6

 

Unknown

17

17.3

Institution Type

Academic

41

41.8

 

Private

31

31.6

 

Public

20

20.4

 

Unknown

6

6.1

Uveitis Subtype

Posterior

41

41.8

 

Intermediate

12

12.2

 

Anterior

9

9.2

 

Uveitic Macular Oedema

6

6.1

 

General/Unspecified

30

30.6

  1. Note: Sponsor and institution classifications are not mutually exclusive; academic or public sites may conduct privately funded trials.
Back to article page